Valuation: Amarin Corporation plc

Market Cap 279M 245M 231M 211M 394M 26.72B 397M 2.77B 1.07B 13.65B 1.05B 1.02B 43.88B P/E 2026 *
-189x
P/E 2027 * -220x
Enterprise Value 117M 102M 96.59M 88.02M 165M 11.17B 166M 1.16B 448M 5.71B 438M 428M 18.34B EV / Sales 2026 *
0.66x
EV / Sales 2027 * 0.59x
Free-Float
86.93%
Yield 2026 *
-
Yield 2027 * -
1 day-1.71%
1 week-3.15%
Current month-4.90%
1 month-8.17%
3 months-17.03%
6 months-10.02%
Current year-5.41%
1 week 13
Extreme 13
13.9
1 month 13
Extreme 13
14.9
Current year 12.96
Extreme 12.96
17.31
1 year 12.96
Extreme 12.96
20.9
3 years 7.08
Extreme 7.08
27.4
5 years 7.08
Extreme 7.08
107.2
10 years 7.08
Extreme 7.08
522.4
Manager TitleAgeSince
Chief Executive Officer 63 04/06/2024
Director of Finance/CFO 42 23/10/2024
Compliance Officer 56 15/11/2023
Director TitleAgeSince
Director/Board Member 63 04/06/2024
Director/Board Member 43 28/02/2023
Director/Board Member 67 28/02/2023
Date Insider Type Main position Quantity % Market Cap. Importance
1/8/26 Exercice

Chief Financial Officer

781 0.0002%
1/7/26 Exercice

Chief Operating Officer

9,302 0.0022%
1/7/26 Exercice

Chief Technology Officer

9,263 0.0022%
Change 5-day change 1-year change 3-year change Capi.($)
-1.71%-3.15%-17.50%-21.89% 279M
-3.30%+1.50%+57.79%+99.14% 72.26B
+1.25%-3.01%+37.83%+87.66% 60.24B
+2.12%+5.26%+35.69%+23.40% 27.73B
-3.06%-1.81%-14.01%+357.24% 25.73B
-0.75%+2.56%+0.45%-3.28% 24.75B
+0.40%+0.75%+23.72%-11.33% 20.74B
-1.70%-2.12%+150.24%+326.97% 15.06B
+0.36%-0.34%+48.98%+167.40% 14.41B
+0.21%+1.17%-3.95%+512.06% 14.23B
Average -0.62%+0.08%+31.92%+153.74% 27.54B
Weighted average by Cap. -0.77%+0.31%+38.10%+132.84%

Financials

2026 *2027 *
Net sales 177M 156M 147M 134M 251M 17.01B 253M 1.76B 682M 8.69B 666M 652M 27.92B 177M 155M 147M 134M 250M 16.95B 252M 1.75B 679M 8.66B 664M 650M 27.83B
Net income -26.62M -23.36M -22.06M -20.11M -37.64M -2.55B -37.91M -264M -102M -1.3B -99.96M -97.8M -4.19B -18.32M -16.07M -15.18M -13.84M -25.9M -1.76B -26.08M -182M -70.37M -897M -68.78M -67.29M -2.88B
Net Debt -162M -142M -134M -123M -229M -15.55B -231M -1.61B -623M -7.95B -609M -596M -25.54B -175M -153M -145M -132M -247M -16.76B -249M -1.73B -672M -8.56B -657M -642M -27.52B
Logo Amarin Corporation plc
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Employees
80
Date Price Change Volume
25/09/26 US$13.20 -1.71% 127,281
24/09/26 US$13.43 -2.11% 47,935
23/09/26 US$13.72 -0.22% 59,839
22/09/26 US$13.75 +2.00% 59,062
21/09/26 US$13.48 -1.10% 38,789
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
2
Last Close Price
13.20USD
Average target price
12.50USD
Spread / Average Target
-5.30%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMRN Stock